关注
Vasilisa A Rudneva
标题
引用次数
引用次数
年份
Pan-cancer analysis of whole genomes
Nature 578 (7793), 82-93, 2020
1970*2020
The landscape of genomic alterations across childhood cancers
SN Gröbner, BC Worst, J Weischenfeldt, I Buchhalter, K Kleinheinz, ...
Nature 555 (7696), 321-327, 2018
14402018
The whole-genome landscape of medulloblastoma subtypes
PA Northcott, I Buchhalter, AS Morrissy, V Hovestadt, J Weischenfeldt, ...
Nature 547 (7663), 311-317, 2017
10432017
Risk-adapted therapy for young children with medulloblastoma (SJYC07): therapeutic and molecular outcomes from a multicentre, phase 2 trial
GW Robinson, VA Rudneva, I Buchhalter, CA Billups, SM Waszak, ...
The Lancet Oncology 19 (6), 768-784, 2018
2222018
Tumour-associated macrophages exhibit anti-tumoural properties in Sonic Hedgehog medulloblastoma
V Maximov, Z Chen, Y Wei, MH Robinson, CJ Herting, NS Shanmugam, ...
Nature communications 10 (1), 2410, 2019
962019
Lsd1 as a therapeutic target in Gfi1-activated medulloblastoma
C Lee, VA Rudneva, S Erkek, M Zapatka, LQ Chau, ...
Nature communications 10 (1), 332, 2019
722019
Comprehensive molecular and clinicopathologic analysis of 200 pulmonary invasive mucinous adenocarcinomas identifies distinct characteristics of molecular subtypes
JC Chang, M Offin, C Falcon, D Brown, BR Houck-Loomis, F Meng, ...
Clinical Cancer Research 27 (14), 4066-4076, 2021
672021
Phase II study of nonmetastatic desmoplastic medulloblastoma in children younger than 4 years of age: a report of the Children’s Oncology Group (ACNS1221)
L Lafay-Cousin, E Bouffet, D Strother, V Rudneva, C Hawkins, C Eberhart, ...
Journal of Clinical Oncology 38 (3), 223-231, 2020
582020
Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples
MH Bailey, WU Meyerson, LJ Dursi, LB Wang, G Dong, WW Liang, ...
Nature communications 11 (1), 4748, 2020
442020
Synergism of checkpoint inhibitors and peptide receptor radionuclide therapy in the treatment of pituitary carcinoma
AL Lin, V Tabar, RJ Young, M Cohen, J Cuaron, TJ Yang, M Rosenblum, ...
Journal of the Endocrine Society 5 (10), bvab133, 2021
322021
ICGC PedBrain-Seq Project; ICGC MMML-Seq Project
SN Gröbner, BC Worst, J Weischenfeldt, I Buchhalter, K Kleinheinz, ...
The landscape of genomic alterations across childhood cancers. Nature 555 …, 2018
322018
Avelumab plus talazoparib in patients with BRCA1/2-or ATM-altered advanced solid tumors: results from JAVELIN BRCA/ATM, an open-label, multicenter, phase 2b, tumor-agnostic trial
AM Schram, N Colombo, E Arrowsmith, V Narayan, K Yonemori, ...
JAMA oncology 9 (1), 29-39, 2023
312023
Genome-wide loss of heterozygosity predicts aggressive, treatment-refractory behavior in pituitary neuroendocrine tumors
AL Lin, VA Rudneva, AL Richards, Y Zhang, HJ Woo, M Cohen, J Tisnado, ...
Acta neuropathologica 147 (1), 1-15, 2024
72024
Author Correction: Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing
I Cortés-Ciriano, JJK Lee, R Xi, D Jain, YL Jung, L Yang, D Gordenin, ...
nature genetics 55 (6), 1076-1076, 2023
22023
Author Correction: Pan-cancer analysis of whole genomes
Nature 614 (7948), E39-E39, 2023
22023
MBCL-08. Molecular characterization of nodular desmoplastic medulloblastomas in young children treated on ACNS1221. A report from the Children Oncology Group
L Lafay-Cousin, G Robinson, V Rudneva, P Northcott, C Billups, ...
Neuro-Oncology 20 (suppl_2), i118-i119, 2018
12018
MBCL-21. EARLY CHILDHOOD MEDULLOBLASTOMA: SUBGROUP-SPECIFIC SURVIVAL IN PATIENTS TREATED WITH SYSTEMIC CHEMOTHERAPY AND INTRAVENTRICULAR MTX TO AVOID CRANIOSPINAL RADIOTHERAPY
M Mynarek, M Kool, U Schueller, K von Hoff, T Sharma, V Rudneva, ...
Neuro-Oncology 20 (suppl_2), i121-i121, 2018
12018
MBRS-34. Molecular characterization of recurrent medulloblastoma reveals an unexpectedly high incidence of secondary malignancy
R Kumar, M Deng, VA Rudneva, GW Robinson, G Dhall, LJ Klesse, ...
Neuro-oncology 20 (suppl_2), i135-i135, 2018
12018
Applicability of coexpression networks analysis to anticancer drug targets discovery
AE Ivliev, VA Rudneva, MG Sergeeva
M.G. Mol Biol 44 (2), 326–333, 2010
12010
Loss of heterozygosity predicts treatment-refractory behavior in pituitary neuroendocrine tumors
A Lin, V Rudneva, A Richards, Y Zhang, M Rosenblum, M Donoghue, ...
Endocrine Abstracts 99, 2024
2024
系统目前无法执行此操作,请稍后再试。
文章 1–20